Parent training to boost medication adherence in pediatric leukemia
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study tests a new parenting program to help improve how well children with leukemia take their oral medications at home. The program focuses on building helpful skills for giving daily medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are the parent or guardian who primarily gives your child their medications.
- Your child is between 3 and 9 years old and has been diagnosed with acute lymphoblastic leukemia (ALL).
- Your child is currently taking an oral anti-cancer medication at home, such as 6-MP.
- You are fluent in English or Spanish.
- You are willing to follow the study instructions and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial tests a specific treatment protocol for children and teens newly diagnosed with certain types of leukemia, aiming to improve outcomes while managing side effects. You may be invited if your child’s leukemia type and timing fit the study rules.
This study tests a support program that helps parents give their child's daily leukemia medicine (6-MP) on schedule and overcome any barriers. It aims to make it easier for families to stick with treatment.
This trial tests a mobile (phone) health program to help adolescents and young adults with leukemia take their oral chemotherapy medicine consistently. It may help if staying on daily pills is hard during the maintenance phase of treatment.
This trial tests whether using a mobile app to track daily medication and weekly blood tests can help children with acute lymphoblastic leukemia (ALL) continue maintenance therapy safely at home, without needing to stay in the hospital.
This study tests a social media-based program to help young people with ALL remember to take their 6-MP medication during maintenance treatment. It aims to improve medication adherence through peer support and reminders.
This study tests a program that helps caregivers remember to give their child's oral medications after a bone marrow transplant. If you are the main caregiver for a child who had a transplant and is still in the hospital, this trial might be for you.
Hear when a new Acute Lymphoblastic Leukemia, Pediatric trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.